Durrer Center for Cardiogenetic Research
The Durrer Center for Cardiovascular Research (Durrer Center) was founded in 2008 as a part of the Netherlands Heart Institute to facilitate cardiovascular researchers in autonomous and secure storage of biosamples and (imaging)data.
Durrer Center facilities
- a transparent and secure storage of samples and data collected from patients with cardiovascular (genetic) diseases
- awareness of the collected samples within the research community leading to additional future research collaborations through catalogs
- transparent data/sample access procedures (e.g. written procedures, collaboration contracts).
Durrer Center has an independent position regarding suppliers or financiers in terms of scientific content and professional responsibility and is an independent partner to centrally stored samples / data from collaborative projects. Durrer Center has developed standard procedures for all processes, which are currently being implemented in a quality management system (ISO9001: 2015).Durrer Center is housed in Academic Medical Center (AMC) and works closely together with the AMC Biobank.
- Cryo storage at +4oC, -80oC and -196oC with 24h monitoring
- Infrastructure for collecting and distributing samples
- Equipment for transporting samples (+4oC, -80oC and -196oC)
- Sample tracking using Biobank Management Information System
- Virtual biobanking:
- Virtual repository of sample (meta) data from samples stored at different local biobanks within a multi-center study
- Data management:
- Development of formats for (multi-center) registries and standard electronic case records forms (eCRFs in OpenClinica/RedCap) for clinical data collection
- Development of catalogs on study level or patient level
- Implementation of infrastructure for imaging archive
At the moment Durrer Center manages the samples and/or data of 24 (multi)center studies covering more than 120.000 samples and developed 13 eCRFs. Durrer Center collaborates with national and international partners such as CTMM (Center for Translational Molecular Medicine), BBMRI-NL and A*STAR (Singapore).